Identification | More | [Name]
BENZYL 3-(HYDROXYMETHYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE | [CAS]
39945-51-2 | [Synonyms]
1-BENZYLOXYCARBONYL-3-(HYDROXYMETHYL)PIPERIDINE 1-CBZ-3-HYDROXYMETHYL-PIPERIDINE 3-HYDROXYMETHYL-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER BENZYL 3-(HYDROXYMETHYL)PIPERIDINE-1-CARBOXYLATE BENZYL 3-(HYDROXYMETHYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE BUTTPARK 75\50-54 N-Cbz-3-hydroxymethylpiperidine | [Molecular Formula]
C14H19NO3 | [MDL Number]
MFCD03407298 | [Molecular Weight]
249.31 | [MOL File]
39945-51-2.mol |
Safety Data | Back Directory | [Symbol(GHS) ]
 GHS07 | [Signal word ]
Warning | [Hazard statements ]
H315-H319-H335 | [Precautionary statements ]
P261-P280a-P304+P340-P305+P351+P338-P405-P501a | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [HS Code ]
29333990 |
Hazard Information | Back Directory | [Chemical Properties]
White to off-white crystal powder | [Uses]
Benzyl 3-(Hydroxymethyl)piperidine-1-carboxylate is an intermediate used in the synthesis of disubstituted pyrimidines as Lck inhibitors. | [Synthesis]
Triethylamine (0.51 g, 5 mmol) was added to a frozen solution of 3-hydroxymethylpiperidine (0.61 g, 5 mmol) in dichloromethane (10 mL), followed by slow dropwise addition of benzyl chloroformate (0.88 g, 5 mmol). The reaction mixture was gradually warmed to room temperature and stirred continuously overnight. After completion of the reaction, dichloromethane (50 mL) was added to dilute the reaction mixture, and the organic layer was washed sequentially with 5% hydrochloric acid solution (2 × 20 mL), saturated sodium bicarbonate solution (20 mL), and saturated sodium chloride solution (20 mL). The organic layer was dried over anhydrous sodium sulfate, filtered to remove the desiccant, and concentrated under reduced pressure to remove the solvent. The crude product was purified by fast column chromatography (silica gel, ethyl acetate/hexane as eluent) to afford the target compound 3-methanol-N-benzyloxycarbonylpiperidine (1.21 g, 96% yield) as a colorless oil.1H NMR (CDCl3) δ: 1.20-1.83 (m, 5H), 2.78-3.20 (m, 2H), 3.50 (s, 2H), 3.69-4.05 (m, 2H), 5.14 (s, 2H), 7.25-7.40 (m, 5H). | [References]
[1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 20, p. 5975 - 5983 [2] Journal of Medicinal Chemistry, 2006, vol. 49, # 9, p. 2673 - 2676 [3] Patent: WO2005/806, 2005, A2. Location in patent: Page 85 [4] Patent: US2010/48606, 2010, A1. Location in patent: Page/Page column 32 [5] Patent: EP1780210, 2007, A1. Location in patent: Page/Page column 51 |
|
|